Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nazem Atassi, MD, MMSc
Masaschusetts General Hospital, Boston, MA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Massachusetts Medical Center
Worcester, Massachusetts, United States
- Washington University at St. Louis
St Louis, Missouri, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Carolinas Medical Center
Charlotte, North Carolina, United States
- Pennsylvania State University, Hershey Medical Center
Hershey, Pennsylvania, United States
- University of Washington Medical Center
Seattle, Washington, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2011
- Primary completion
- 31 Dec 2012
- Completion
- 28 Feb 2013
- Last update posted
- 4 Dec 2014
- Registered enrollment
- 60
- Registry id
- NCT01257581
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.